syringic acid has been researched along with Ovarian Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, J; Pei, L; Qu, C; Yang, H; Yang, L | 1 |
| Chen, L; Li, Y; Liang, Y; Liu, J; Wang, W; Zhao, S | 1 |
2 other study(ies) available for syringic acid and Ovarian Neoplasms
| Article | Year |
|---|---|
Syringic acid regulates suppression of the STAT3/JNK/AKT pathway via inhibition of human ovarian teratoma cancer cell (PA-1) growth-in vitro study.
Topics: Cell Line, Tumor; Cell Proliferation; Female; Gallic Acid; Humans; MAP Kinase Kinase 4; Ovarian Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; STAT3 Transcription Factor; Teratoma | 2021 |
Chemoprotective Effect of Syringic Acid on Cyclophosphamide Induced Ovarian Damage via Inflammatory Pathway.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antioxidants; Chemoprevention; Cyclophosphamide; Cytokines; Dose-Response Relationship, Drug; Female; Gallic Acid; Humans; Inflammation Mediators; Ovarian Neoplasms; Oxidative Stress; Rats, Wistar; Signal Transduction | 2021 |